Florida Perinatal Quality Collaborative

Located at:

Image

Hypertension in Pregnancy (HIP)

Image
 From 1999-2012 hypertensive disorders were the leading cause of pregnancy-related deaths accounting for 15.5% of such deaths in Florida. Maternal mortality review reports from North Carolina and California found that maternal deaths due to hypertensive disorders had significant prevention opportunities.


NEWS:
  • Sustaining HIP Standardization of Practice Webinar slides and recording added below to Archived Webinars.

  • Physicians can get MOC credit for the HIP Initiative in 2016 and 2017. Download the information sheet and share it with your physicians! Great engagement tool.

  • We received questions regarding the use of oral Labetalol and having it be considered for documentation of treatment within one hour. The FPQC toolkit does list both oral Nifedipine and Labetalol as options when there is no IV access, our data collection continues to allow Nifedipine only to be listed as treatment within one hour of identification of severe hypertension. The rationale for this is: Nifedipine is preferred if you need to use an oral agent because its onset/peak of action is faster. It peaks at 60 minutes whereas oral labetalol takes a couple of hours to peak. Oral Labetalol meets criteria only when the other agents are not available or if there is no IV access. We hope this clarification is helpful to you as you continue your work to improve patient safety in hypertensive crises.





Initiative Focus

  • Reduction of short and long-term morbidity and mortality related to pregnancy hypertension.
  • Proper screening, diagnosis and management of hypertensive disorders.
  • Timely recognition and quick, organized response to preeclampsia.
  • Proper discharge screening and planning, including patient education.

Questions: fpqc@health.usf.edu


  • HIP Sustainability Data Checks

    We want to make sure your hospitals does not regress in Hypertension in Pregnancy quality measures now that the initiative, and associated monthly data submission, has come to an end. We will be implementing periodic Sustainability Indicator Checks. We will request HIP hospital data and create a data report on a quarterly basis, rather than monthly. 

    Starting with July 2017 charts, we ask that you audit at least the first 10 charts of each quarter and only submit data once per quarter to help you in on-going measurement and management.   HIP Hospitals' first Sustainability Check will be on data for Q3 of 2017 (July, August, September). We will send a link in October requesting your first chart audit submission. 

    Sustainability Data Collection Sheet

    Initially, data will be collected for two quarters (Q3 and 4 of 2017) and then semi and then semi-annually in 2018. For example, HIP hospitals will submit for 3 months of data in Q3, 3 months of data in Q4, and then submit for 6 months of data in June 2018 and again in December 2018. Hospital reports will be generated by the FPQC at the end of each time period. 

  • HIP Resources and Tool Box

    Please click here to access the HIP Initiative's Tool Box. 

    This online tool box contains our toolkit, algorithms, slide sets, patient education materials, resources on simulation drills and debriefs, sample policies and protocols, example implementation tools from other hospitals, and information on our data measures. 

    Interested in tracking your own data on Hypertension in Pregnancy? Download our Data Entry and Display Spreadsheet!

  • HIP Archived Webinars

    If you have trouble accessing recordings, please contact FPQC@health.usf.edu


    May 3, 2018 - Sustaining HIP Standardization of Practice: Lessons and Success Stories - View Recording - Download Slides